OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • The OncLive Insider app is live!
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Expert Review on the Multidisciplinary Management of Bladder Cancer

home / insights / bladder-cancer
Introduction: Neoadjuvant Chemotherapy in Bladder Cancer

EP. 1: Introduction: Neoadjuvant Chemotherapy in Bladder Cancer

March 27th 2015
Lymph Node Dissection in Bladder Cancer

EP. 2: Lymph Node Dissection in Bladder Cancer

March 27th 2015
Managing Renal Pelvis Transitional Cell Carcinoma

EP. 3: Managing Renal Pelvis Transitional Cell Carcinoma

March 27th 2015
Neoadjuvant and Adjuvant Therapy in Bladder Cancer

EP. 4: Neoadjuvant and Adjuvant Therapy in Bladder Cancer

March 27th 2015
Multidisciplinary Approach in Muscle-Invasive Bladder Cancer

EP. 5: Multidisciplinary Approach in Muscle-Invasive Bladder Cancer

March 27th 2015
Cisplatin-Based Therapy in Muscle-Invasive Bladder Cancer

EP. 6: Cisplatin-Based Therapy in Muscle-Invasive Bladder Cancer

March 27th 2015
Treating Relapsed Muscle-Invasive Bladder Cancer

EP. 7: Treating Relapsed Muscle-Invasive Bladder Cancer

March 27th 2015
Potential Targets in Muscle-Invasive Bladder Cancer

EP. 8: Potential Targets in Muscle-Invasive Bladder Cancer

March 27th 2015
Anti-PD-L1 Therapy in Muscle-Invasive Bladder Cancer

EP. 9: Anti-PD-L1 Therapy in Muscle-Invasive Bladder Cancer

March 27th 2015
Novel Therapies Needed for Muscle-Invasive Bladder Cancer

EP. 10: Novel Therapies Needed for Muscle-Invasive Bladder Cancer

March 27th 2015

Latest Conference Coverage

First-Line Rucaparib Maintenance Reduces Progression Risk Across Prognostic Subgroups in HRD– High-Grade Ovarian Cancer

Raludotatug Deruxtecan Shows Activity in Platinum-Sensitive Ovarian Cancer

Relacorilant/Nab-Paclitaxel Is Associated With Survival Improvement in Platinum-Resistant Ovarian Cancer After Short Platinum-Free Interval

PD-L1 CPS Does Not Enrich the Efficacy of Atezolizumab/Bevacizumab and Chemo in Advanced Cervical Cancer

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact